Form D · Other Health Care

CONVALO HEALTH INTERNATIONAL, CORP.

Los Angeles, CA · CIK 0001592022

Offering snapshot reported Nov 4, 2016 · SEC filing

Reported sold: $346K
Investors reported: 5
Minimum accepted: $0
First sale: Oct 20, 2016

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 4, 2016	Initial	$346,079	No comparison	5	SEC filing
Nov 6, 2014	Initial	$222,103	No comparison	2	SEC filing
Apr 17, 2014	Initial	$9,090	No comparison	1	SEC filing
Apr 17, 2014	Initial	$465,626	No comparison	4	SEC filing
Nov 19, 2013	Initial	$23,943	No comparison	1	SEC filing
Nov 14, 2013	Initial	$1,637	No comparison	13	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-273845

13(a) represents the price of the shares ( 4,350,000 shares x C$0.105), converted to US$ based on the exchange rate on the date of closing, October 20, 2016 of C$1.00=US$0.7577.

Source: Form D, filed Nov 4, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Edward Allera	Director
David Costine	Director, Executive
Michael Dalsin	Director
Roger Greene	Director
Nitin Kaushal	Director
Hector Rivera	Executive
Dennis Wilson	Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:

448 S. Hill Street, Suite 301/303
Los Angeles, CA, 90013